Healthcare provider profile · identity verified

Alfredo Vargas, MD

Family Practice · PUEBLO, CO · NPI 1396753521

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	414	102
Lisinopril	Lisinopril	310	73
Amlodipine Besylate	Amlodipine Besylate	205	47
Metformin Hcl	Metformin Hcl	199	48
Albuterol Sulfate Hfa	Albuterol Sulfate	158	30
Omeprazole	Omeprazole	144	44
Hydrochlorothiazide	Hydrochlorothiazide	117	33
Gabapentin	Gabapentin	105	25
Losartan Potassium	Losartan Potassium	103	23
Tamsulosin Hcl	Tamsulosin Hcl	96	31
Rosuvastatin Calcium	Rosuvastatin Calcium	93	27
Levothyroxine Sodium	Levothyroxine Sodium	88	18
Hydralazine Hcl	Hydralazine Hcl	83	13
Metoprolol Succinate	Metoprolol Succinate	82	16
Trulicity	Dulaglutide	79	23
Ezetimibe	Ezetimibe	78	15
Escitalopram Oxalate	Escitalopram Oxalate	70	18
Furosemide	Furosemide	70	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	45	suppressed
Potassium Chloride	Potassium Chloride	45	14
Fluticasone Propionate	Fluticasone Propionate	44	15
Trazodone Hcl	Trazodone Hcl	44	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	43	suppressed
Glipizide	Glipizide	41	suppressed
Tizanidine Hcl	Tizanidine Hcl	41	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Sertraline Hcl	Sertraline Hcl	37	suppressed
Tradjenta	Linagliptin	37	suppressed
Famotidine	Famotidine	36	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	35	suppressed
Carvedilol	Carvedilol	34	11
Oxycodone Hcl	Oxycodone Hcl	33	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	12
Meloxicam	Meloxicam	25	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Ozempic	Semaglutide	22	suppressed
Finasteride	Finasteride	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	16
Glipizide Er	Glipizide	20	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Eliquis	Apixaban	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Allopurinol	Allopurinol	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Baclofen	Baclofen	14	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Minoxidil	Minoxidil	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Probenecid	Probenecid	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	11	11
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Simvastatin	Simvastatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error